0865 Sleep-Disordered Breathing in Children with Achondroplasia: A Longitudinal Assessment of Polysomnogram Results and Treatment Strategies

Abstract Introduction Achondroplasia is the most common skeletal dysplasia. Children with achondroplasia are at risk for sleep-disordered breathing (SDB) throughout infancy and childhood. Polysomnogram (PSG) is recommended in infancy and as-indicated clinically during childhood to screen for and manage SDB. The prevalence and progression of SDB and treatment strategies used over time are not well-described. Methods This IRB-approved, retrospective study describes polysomnogram results and treatment in a cohort of children with achondroplasia from 0-60 months managed from 2010-2025 at a pediatric referral center. All PSG were completed in an AASM-accredited laboratory at a single center; patients were included if baseline study was completed < 12 months of age. Clinical data, PSG results, and treatment strategies were obtained via chart review. Descriptive statistics were used to analyze results and compare treatment strategies by age. Results 74 patients (53% male, 81% white) met inclusion criteria. In the 0-6 month range, 85% had SDB with mean AHI 21.4(21.0), SpO2 nadir 83.9(6.8)%, 2.7% with hypoventilation and most common treatments of watchful waiting (41%) and low-flow oxygen (31%). In the 7-12 month range, 74% with SDB with mean AHI 17.3(20.2), SpO2 nadir 80.7(11)%, 9.5% with hypoventilation and most common treatments of watchful waiting (48%) and medical therapy (14%). In the 13-36 month range, 80% had SDB with mean AHI 20.6(20.5), SpO2 nadir 82.0(12.5)%, 21.4% with hypoventilation and most common treatments of watchful waiting (43%) and ENT surgery (14%). In the 37-60 month range, 76% had SDB with mean AHI 14.8(17.1), SpO2 nadir 85.2(5.7)%, 35.3% with hypoventilation and most common treatments of watchful waiting (58%) and positive pressure therapy (21%). Conclusion SDB was highly prevalent in this cohort of children with achondroplasia, predominantly OSAHS, with differences in OSAHS severity, ventilation, and treatment strategies by age. Although this cohort of referred children represents a population more likely to have SDB, repeat PSGs should be considered over time to evaluate for and manage SDB. Support (if any) None

Authors

Institutions

Publication Details

Journal
SLEEP
Published
2026-05-01
DOI
https://doi.org/10.1093/sleep/zsag091.0864
Primary Topic
Neonatal Respiratory Health Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

0865 Sleep-Disordered Breathing in Children with Achondroplasia: A Longitudinal Assessment of Polysomnogram Results and Treatment Strategies

Connor Devoe, A. Chidekel, Abigail Strang, Seema Rani et al.
SLEEP
Neonatal Respiratory Health Research
article

0865 Sleep-Disordered Breathing in Children with Achondroplasia: A Longitudinal Assessment of Polysomnogram Results and Treatment Strategies

Connor Devoe, A. Chidekel, Abigail Strang, Seema Rani, Mahim Jain, Amanda Belej, Ricki Carroll
article en

Abstract

Abstract Introduction Achondroplasia is the most common skeletal dysplasia. Children with achondroplasia are at risk for sleep-disordered breathing (SDB) throughout infancy and childhood. Polysomnogram (PSG) is recommended in infancy and as-indicated clinically during childhood to screen for and manage SDB. The prevalence and progression of SDB and treatment strategies used over time are not well-described. Methods This IRB-approved, retrospective study describes polysomnogram results and treatment in a cohort of children with achondroplasia from 0-60 months managed from 2010-2025 at a pediatric referral center. All PSG were completed in an AASM-accredited laboratory at a single center; patients were included if baseline study was completed < 12 months of age. Clinical data, PSG results, and treatment strategies were obtained via chart review. Descriptive statistics were used to analyze results and compare treatment strategies by age. Results 74 patients (53% male, 81% white) met inclusion criteria. In the 0-6 month range, 85% had SDB with mean AHI 21.4(21.0), SpO2 nadir 83.9(6.8)%, 2.7% with hypoventilation and most common treatments of watchful waiting (41%) and low-flow oxygen (31%). In the 7-12 month range, 74% with SDB with mean AHI 17.3(20.2), SpO2 nadir 80.7(11)%, 9.5% with hypoventilation and most common treatments of watchful waiting (48%) and medical therapy (14%). In the 13-36 month range, 80% had SDB with mean AHI 20.6(20.5), SpO2 nadir 82.0(12.5)%, 21.4% with hypoventilation and most common treatments of watchful waiting (43%) and ENT surgery (14%). In the 37-60 month range, 76% had SDB with mean AHI 14.8(17.1), SpO2 nadir 85.2(5.7)%, 35.3% with hypoventilation and most common treatments of watchful waiting (58%) and positive pressure therapy (21%). Conclusion SDB was highly prevalent in this cohort of children with achondroplasia, predominantly OSAHS, with differences in OSAHS severity, ventilation, and treatment strategies by age. Although this cohort of referred children represents a population more likely to have SDB, repeat PSGs should be considered over time to evaluate for and manage SDB. Support (if any) None

SLEEPVol. 49(Supplement_1)
Children's Hospital (TN)
Good health and well-being
Openalex Percentile: Top 7%
Neonatal Respiratory Health Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.